HHS WEEKLY REPORT
December 8 - 14, 2003

THIS ISSUE AVAILABLE ONLINE WITH EXPANDED INFORMATION AND PHOTOS AT:
http://www.hhs.gov/news/newsletter/weekly

IN THIS ISSUE:
1) President Signs Medicare Modernization Bill
2) 2003 Innovation in Prevention Awards
3) Science in the News
4) Physical Activity and Health
5) Secretary Thompson's Public Schedule:

President Signs Medicare Modernization Bill

President Bush signed the historic Medicare Modernization bill Dec. 8 that will grant Medicare beneficiaries more preventive health benefits and prescription drug coverage by 2006.

"We finally delivered for seniors," Secretary Thompson said. "Thanks to President Bush's bold leadership and an historic, bipartisan vote in Congress, we delivered the most significant improvement in health care for seniors in nearly 40 years. Seniors will now have access to modern medicine delivered in a modern way."

Some of the new benefits include the "welcome to Medicare" physical for all new beneficiaries beginning in 2005, and screening tests such as the cardiovascular and diabetes screening blood tests to diagnose patients early and educate them so they may take better care of themselves.

The prescription drug card will be available in late spring 2004 for all Medicare beneficiaries and will give immediate assistance to seniors for the cost of their medicines, a savings of 10 - 25 percent.

------------------------------

2003 Innovation in Prevention Awards

Secretary Thompson is hosting the Innovation in Prevention Awards on December 10 in Washington, D.C. The awards are part of a broader initiative Steps to a HealthierUS that aims to decrease the rate of chronic disease and encourage Americans to live longer, healthier lives. The awardees will be announced at a press conference at the National Press Club, and will be celebrated at the Prevention Gala that evening.

The 2003 Secretary's Innovation in Prevention Awards will identify and celebrate outstanding organizations that have implemented innovative health promotion programs. To be considered, the organization must have developed a program that works to decrease risk factors that are proven to cause the following:

The awardees were chosen by an independent expert panel and will be selected according to their program's creativity and innovation, leadership, sustainability, replicability and effectiveness. The eligibility is open to all non-profit, faith based and private organizations.

------------------------------

Science in the News

Scientists who developed the first yeast model of Parkinson's disease (PD) have been able to describe the mechanisms of an important gene's role in the disease. Tiago Fleming Outeiro, Ph.D., and Susan Lindquist, Ph.D., of the Whitehead Institute for Biomedical Research in Cambridge, MA, studied the gene's actions under normal conditions and under abnormal conditions to learn how and when the gene's product, alpha-synuclein, becomes harmful to surrounding cells. The scientists created a yeast model that expresses the alpha-synuclein gene, which has been implicated in Parkinson's disease (PD). Yeast models are often used in the study of genetic diseases because they offer researchers a simple system that allows them to clarify how genes work.

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, funded the study, which appears in the December 5, 2003, issue of Science.

The alpha-synuclein protein, which is found broadly in the brain, has been implicated in several neurodegenerative disorders. Sometimes a mutation or a misfolding of the protein causes the problems; other times there are too many copies of the normal gene. A study earlier this year reported that patients with a rare familial form of PD had too many normal copies of the alpha-synuclein gene, which resulted in a buildup of protein inside brain cells, causing the symptoms of PD.

Drs. Outeiro and Lindquist conducted their study by creating one yeast that expresses wild type synuclein, using the normal gene, and another yeast that expresses two mutant forms, using a mutated version of the gene found in patients with PD.

One theory for the cause of PD is that an aging brain no longer has the capacity to cope with accumulating or misfolding proteins. A normal healthy brain has the ability to clear out excess or mutant proteins through a process known as the quality control system. In the yeast model of PD, when the scientists doubled the expression of the alpha-synuclein gene it "profoundly changed" the fate of the yeast's quality control system, and alpha-synuclein appeared in large clumps of cells (inclusion bodies). This did not happen when they studied the actions of a single copy of the wild type synuclein. These inclusion bodies have a toxic effect that causes cell death and neurodegeneration.

"Just a twofold difference in expression was sufficient to cause a catastrophic change in behavior," the scientists report in their paper.

"These changes may give insight into important changes that happen when alpha-synuclein is overexpressed in Parkinson's patients," said Diane Murphy, Ph.D., a program director at the NINDS. "Dr. Lindquist is well known for her studies of yeast models of prion disease, and we are delighted she has extended her research to the important field of Parkinson's disease."

PD is the second most common neurodegenerative disease after Alzheimer's disease and is thought to affect 500,000 Americans.

The NIH's National Institute of Neurological Disorders and Stroke leads Federal efforts to conduct and support basic and clinical research on diseases of the brain and central nervous system. The agencies are part of the U.S. Department of Health and Human Services.

------------------------------

Personal Health

Physical Activity and Health

FACT SHEET

This information is provided by the President's Council for Physical Fitness and Sports.

------------------------------

Secretary Tommy G. Thompson's public schedule:

------------------------------

FOIA¬Privacy ¬Disclaimers¬Accessibility

Last updated: December 8, 2003
United States Department of Health and Human Services
Contact the HHS Newsletter Team.